Deltex Medical Valuation
| DEMG Stock | 0.08 0.00 0.00% |
Deltex Medical seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Deltex Medical Group from reviewing the firm fundamentals such as Current Valuation of 3.17 M, profit margin of (0.72) %, and Shares Outstanding of 1.9 B as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 0.535 | Enterprise Value 3.2 M | Enterprise Value Ebitda (11.45) | Price Sales 0.8517 | Forward PE 21.645 |
Overvalued
Today
Please note that Deltex Medical's price fluctuation is out of control at this time. Calculation of the real value of Deltex Medical Group is based on 3 months time horizon. Increasing Deltex Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Deltex stock is determined by what a typical buyer is willing to pay for full or partial control of Deltex Medical Group. Since Deltex Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Deltex Stock. However, Deltex Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.08 | Real 0.0767 | Hype 0.08 | Naive 0.0853 |
The intrinsic value of Deltex Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Deltex Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Deltex Medical Group helps investors to forecast how Deltex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Deltex Medical more accurately as focusing exclusively on Deltex Medical's fundamentals will not take into account other important factors: Deltex Medical Cash |
|
Deltex Medical Total Value Analysis
Deltex Medical Group is currently projected to have takeover price of 3.17 M with market capitalization of 1.52 M, debt of 1.92 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Deltex Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.17 M | 1.52 M | 1.92 M |
Deltex Medical Investor Information
About 69.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.54. Some equities with similar Price to Book (P/B) outperform the market in the long run. Deltex Medical Group had not issued any dividends in recent years. The entity had 839:837 split on the 8th of February 2016. Deltex Medical Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Deltex Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Deltex Medical has an asset utilization ratio of 29.94 percent. This implies that the Company is making USD0.3 for each dollar of assets. An increasing asset utilization means that Deltex Medical Group is more efficient with each dollar of assets it utilizes for everyday operations.Deltex Medical Ownership Allocation
Deltex Medical holds a total of 1.9 Billion outstanding shares. Deltex Medical Group shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.63 percent of Deltex Medical Group outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Deltex Medical Profitability Analysis
The company reported the revenue of 1.78 M. Net Loss for the year was (1.26 M) with profit before overhead, payroll, taxes, and interest of 1.84 M.About Deltex Medical Valuation
The stock valuation mechanism determines Deltex Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Deltex Medical Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Deltex Medical. We calculate exposure to Deltex Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Deltex Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.1 M | 1.1 M |
Additional Tools for Deltex Stock Analysis
When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.